BioSpace News Archive

Immunovia AB announced the company’s long-term market penetration target of 30% for IMMray™ PanCan-d, after reimbursement and widespread insurance coverage is achieved.

There has been an increase in the possibility for the ‘conquering of cancer’ as test results confirm, for the first time, the disappearance of tumors upon administering a ‘pain-free anticancer drug.’

Attana has today released the initial technical protocols for AVA Antibody Testing and will make these available to all existing Attana customers.

Immunovia AB announced that the number of shares and votes in Immunovia has changed due to the fact that shares have been registered after the directed share issue which was carried out in June 2020.

C-RAD has signed a Letter of Intent with the Belgium company Ion Beam Applications SA, regarding the supply of C-RAD’s surface tracking solution.

IRRAS AB, a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, provided an update on the launch of its IRRAflow® and Hummingbird ICP Monitoring product lines during the evolving global COVID-19 pandemic.

Guardion Health Sciences, Inc. announced that it has completed shipment of Astramern to Astramune Sdn Bhd, a subsidiary of Ho Wah Genting Berhad, a Malaysian company listed on the Malaysian Stock Exchange.

TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need in pain management, ophthalmology and oncology, is pleased to announce that it has closed its 2020 cash capital offering of ordinary shares in Taiwan, with the record date of June 30, 2020.

Kurin Inc., the inventor and manufacturer of 510-cleared Kurin® blood culture collection sets, announced that it has been awarded a contract by Intalere for the Kurin product line.

IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics based on Synthetic Lethality, announced the appointment of Garret Hampton, Ph.D., to its Board of Directors.